selenium has been researched along with ruthenium in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (15.00) | 29.6817 |
| 2010's | 10 (50.00) | 24.3611 |
| 2020's | 5 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Terada, K | 1 |
| De Corte, F; Hoste, J; Van der Linden, R | 1 |
| Behm, RJ; Colmenares, L; Jusys, Z | 1 |
| Bonakdarpour, A; Delacôte, C; Johnston, CM; Wieckowski, A; Zelenay, P | 1 |
| Babu, PK; Bonakdarpour, A; Ernst, F; Guinel, MJ; Mukerjee, S; Ramaswamy, N; Wang, B; Wieckowski, A | 1 |
| Iron, MA; Konstantinovski, L; Laskavy, A; Neumann, R; Shimon, LJ | 1 |
| Chen, X; Hong, A; Liu, J; Liu, Y; Sun, D; Yu, Q; Zhang, R; Zhou, Y | 1 |
| Chen, L; Liu, J; Liu, Y; Qin, X; Sun, D; Yang, L; Yu, Q; Zhou, Y | 1 |
| Cao, W; Chen, T; Deng, Z; Yu, L; Zheng, W | 1 |
| Bhavsar, D; Chen, LM; Chen, Q; Liu, J; Liu, Y; Ren, X; Sun, D; Yang, L; Yu, Q; Zheng, W | 1 |
| Bai, Y; Chen, L; Deng, Y; Liu, J; Liu, Y; Xu, M; Zhou, Y | 1 |
| Chen, Q; Deng, H; Liu, J; Xu, M; Xu, T; Zheng, W | 1 |
| Chen, X; Huang, N; Liu, J; Xu, M; Zhu, X | 1 |
| Chen, T; Gao, P; You, Y; Zhao, Z | 1 |
| Chen, T; Lai, H; Liu, C; Wang, X; Zeng, D; Zhang, Q | 1 |
| Cen, J; Chen, X; Gong, Y; Guo, X; Huang, Y; Jia, Z; Li, J; Liu, J; Liu, Y; Yuan, X | 1 |
| Mehta, KJ | 1 |
| Chen, ZX; Huang, HY; Liao, XW; Wang, JT; Wang, Q; Xiong, YS; Yu, RJ; Zhang, CY | 1 |
| Chen, D; Chen, M; Chen, T; Jia, W; Li, Y; Su, J; Zhu, B | 1 |
| Chan, L; Chen, T; Liu, T; Shi, C; Yuan, Z; Zhao, J | 1 |
1 review(s) available for selenium and ruthenium
| Article | Year |
|---|---|
Iron Oxide Nanoparticles in Mesenchymal Stem Cell Detection and Therapy.
Topics: Animals; Contrast Media; Dextrans; Doxorubicin; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Fibroblast Growth Factor 2; Gadolinium; Glucosamine; Gold; Magnetic Iron Oxide Nanoparticles; Mesenchymal Stem Cells; Polyethylene Glycols; Polyglactin 910; Polylysine; Ruthenium; Selenium; Silicon Dioxide; Zinc | 2022 |
19 other study(ies) available for selenium and ruthenium
| Article | Year |
|---|---|
[Application of strong phosphoric acid to radiochemistry (author's transl)].
Topics: Cerium; Chromium; Electricity; Ferrous Compounds; Iodates; Methods; Minerals; Osmium; Phosphoric Acids; Radioactive Tracers; Radiochemistry; Radioisotopes; Ruthenium; Selenium; Solubility; Uranium | 1977 |
Activation analysis of biological maternal with ruthenium as a multi-isotopic comparator.
Topics: Activation Analysis; Animals; Cattle; Cobalt; Iron; Liver; Metals; Rubidium; Ruthenium; Selenium; Zinc | 1974 |
Electrochemical surface characterization and O2 reduction kinetics of Se surface-modified ru nanoparticle-based RuSe(y)/C catalysts.
Topics: Carbon; Electrochemistry; Kinetics; Nanoparticles; Oxidation-Reduction; Oxygen; Ruthenium; Selenium; Surface Properties; Time Factors | 2006 |
Aqueous-based synthesis of ruthenium-selenium catalyst for oxygen reduction reaction.
Topics: Catalysis; Computer Simulation; Electric Power Supplies; Electrochemistry; Electrodes; Electron Transport; Models, Chemical; Oxidation-Reduction; Oxygen; Ruthenium; Selenium; Surface Properties; Water | 2008 |
Carbon-supported, selenium-modified ruthenium-molybdenum catalysts for oxygen reduction in acidic media.
Topics: Carbon; Catalysis; Electrochemistry; Metal Nanoparticles; Microscopy, Electron, Transmission; Molybdenum; Oxidation-Reduction; Oxygen; Ruthenium; Selenium; X-Ray Diffraction | 2009 |
Activation of molecular oxygen by a dioxygenase pathway by a ruthenium bis-bipyridine compound with a proximal selenium site.
Topics: Binding Sites; Crystallography, X-Ray; Dioxygenases; Models, Molecular; Molecular Structure; Organometallic Compounds; Oxygen; Pyridines; Ruthenium; Selenium | 2010 |
The effects of luminescent ruthenium(II) polypyridyl functionalized selenium nanoparticles on bFGF-induced angiogenesis and AKT/ERK signaling.
Topics: Animals; Annexin A5; Apoptosis; Cell Movement; Cell Survival; Chickens; Chorioallantoic Membrane; Circular Dichroism; Endocytosis; Extracellular Signal-Regulated MAP Kinases; Fibroblast Growth Factor 2; Hep G2 Cells; Human Umbilical Vein Endothelial Cells; Humans; Inhibitory Concentration 50; Luminescent Measurements; MAP Kinase Signaling System; Nanoparticles; Neovascularization, Physiologic; Phosphorylation; Prophase; Proto-Oncogene Proteins c-akt; Pyridines; Ruthenium; Selenium | 2013 |
Inhibition of tumor growth and vasculature and fluorescence imaging using functionalized ruthenium-thiol protected selenium nanoparticles.
Topics: Animals; Cells, Cultured; Fluorescence; Hep G2 Cells; Heterografts; Humans; Liver Neoplasms; Male; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Mice, Nude; Microscopy, Electron, Transmission; Neovascularization, Pathologic; Ruthenium; Selenium; Sulfhydryl Compounds | 2014 |
A selenium-containing ruthenium complex as a cancer radiosensitizer, rational design and the important role of ROS-mediated signalling.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; DNA Damage; Drug Design; G2 Phase Cell Cycle Checkpoints; Humans; M Phase Cell Cycle Checkpoints; Molecular Structure; Neoplasms; Organometallic Compounds; Radiation-Sensitizing Agents; Reactive Oxygen Species; Ruthenium; Selenium; Signal Transduction; Structure-Activity Relationship | 2015 |
Multifunctional selenium nanoparticles: Chiral selectivity of delivering MDR-siRNA for reversal of multidrug resistance and real-time biofluorescence imaging.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Gene Transfer Techniques; Humans; Nanoparticles; Neoplasms; RNA, Small Interfering; Ruthenium; Selenium | 2015 |
Green synthesis of Se/Ru alloy nanoparticles using gallic acid and evaluation of theiranti-invasive effects in HeLa cells.
Topics: Alloys; Antineoplastic Agents; Apoptosis; Cell Movement; Cell Proliferation; Gallic Acid; Green Chemistry Technology; HeLa Cells; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Metal Nanoparticles; Neoplasm Invasiveness; Particle Size; Ruthenium; Selenium; X-Ray Diffraction | 2016 |
Se/Ru-Decorated Porous Metal-Organic Framework Nanoparticles for The Delivery of Pooled siRNAs to Reversing Multidrug Resistance in Taxol-Resistant Breast Cancer Cells.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Metal-Organic Frameworks; Mice; Mice, Nude; Nanoparticles; Paclitaxel; Phosphatidylinositol 3-Kinases; RNA, Small Interfering; Ruthenium; Selenium | 2017 |
Ruthenium complexes/polypeptide self-assembled nanoparticles for identification of bacterial infection and targeted antibacterial research.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Coordination Complexes; Drug Delivery Systems; Drug Synergism; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; NIH 3T3 Cells; Optical Imaging; Peptides; Ruthenium; Selenium; Theranostic Nanomedicine | 2017 |
Cancer-Targeting Functionalization of Selenium-Containing Ruthenium Conjugate with Tumor Microenvironment-Responsive Property to Enhance Theranostic Effects.
Topics: Antineoplastic Agents; Apoptosis; Humans; Ligands; Mitochondria; Ruthenium; Selenium; Signal Transduction; Theranostic Nanomedicine; Tumor Microenvironment | 2018 |
Selenium-containing ruthenium complex synergizes with natural killer cells to enhance immunotherapy against prostate cancer via activating TRAIL/FasL signaling.
Topics: Cell Degranulation; Cytotoxicity, Immunologic; DNA Damage; Fas Ligand Protein; fas Receptor; Humans; Immunotherapy; Killer Cells, Natural; Male; Prostatic Neoplasms; Reactive Oxygen Species; Receptors, Death Domain; Ruthenium; Selenium; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand; Up-Regulation | 2019 |
A diselenide bond-containing ROS-responsive ruthenium nanoplatform delivers nerve growth factor for Alzheimer's disease management by repairing and promoting neuron regeneration.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biocompatible Materials; Blood-Brain Barrier; Brain; Cell Line, Tumor; Drug Carriers; Hemolysis; Humans; Infrared Rays; Nanostructures; Nerve Growth Factor; Nerve Regeneration; Neuronal Outgrowth; Reactive Oxygen Species; Ruthenium; Selenium | 2021 |
Synthesis and biological evaluation of ruthenium complexes containing phenylseleny against Gram-positive bacterial infection by damage membrane integrity and avoid drug-resistance.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Coordination Complexes; Drug Resistance; Gram-Positive Bacterial Infections; Mammals; Mice; Microbial Sensitivity Tests; Ruthenium; Selenium; Staphylococcus aureus | 2023 |
Selenium-ruthenium complex blocks H1N1 influenza virus-induced cell damage by activating GPx1/TrxR1.
Topics: Animals; Antiviral Agents; Influenza A virus; Influenza A Virus, H1N1 Subtype; Mice; Ruthenium; Selenium | 2023 |
X-ray sensitive selenium-containing Ru complexes sensitize nasopharyngeal carcinoma cells for radio/chemotherapy.
Topics: Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Radiation-Sensitizing Agents; Reactive Oxygen Species; Ruthenium; Selenium; X-Rays | 2023 |